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AbsTrACT
background and aims Little is known about the 
relationship between inflammatory bowel disease (IBD) 
and body image. The aim of this systematic review was to 
summarise the evidence on body image dissatisfaction in 
patients with IBD across four areas: (1) body image tools, 
(2) prevalence, (3) factors associated with body image 
dissatisfaction in IBD and (4) association between IBD and 
quality of life.
Methods Two reviewers screened, selected, quality 
assessed and extracted data from studies in duplicate. 
EMBASE, MEDLINE, PsycINFO and Cochrane CENTRAL 
were searched to April 2018. Study design–specific critical 
appraisal tools were used to assess risk of bias. Narrative 
analysis was undertaken due to heterogeneity.
results Fifty-seven studies using a body image tool were 
included; 31 for prevalence and 16 and 8 for associated 
factors and association with quality of life, respectively. 
Studies reported mainly mean or median scores. Evidence 
suggested female gender, age, fatigue, disease activity 
and steroid use were associated with increased body 
image dissatisfaction, which was also associated with 
decreased quality of life.
Conclusion This is the first systematic review on body 
image in patients with IBD. The evidence suggests that 
body image dissatisfaction can negatively impact patients, 
and certain factors are associated with increased body 
image dissatisfaction. Greater body image dissatisfaction 
was also associated with poorer quality of life. However, 
the methodological and reporting quality of studies was in 
some cases poor with considerable heterogeneity. Future 
IBD research should incorporate measurement of body 
image dissatisfaction using validated tools.
IntroductIon
Inflammatory bowel disease (IBD) is asso-
ciated with a range of debilitating symp-
toms1 and affects around 300 000 people in 
the UK2, over 1 million in the USA and 2.5 
million across Europe.3 A potentially over-
looked issue for patients with IBD is body 
image dissatisfaction (BID). Body image (BI) 
is how an individual perceives themselves 
physically4 and sufferers have a distorted and 
negative view of themselves, feeling anxious 
and uncomfortable about their body. Addi-
tionally, negative BI can have a serious impact 
on health and well-being.5
Social media and celebrity attention 
contribute to pressure to adhere to an 
‘ideal’ body and an obsession with appear-
ance.6 7 Discontentment with aspects such as 
body weight, shape, appearance and skin may 
contribute towards an individual having BID.8 
Studies have shown patients with negative 
BI are more likely to suffer with depression, 
anxiety and feel suicidal and BID can impact 
negatively on relationships9 and quality of life 
(QoL).10.
Various tools have been used in healthcare 
to measure BI including the Body Image 
Ideals Questionnaire, the Body Image Scale 
and the Cash Body Image Disturbance Ques-
tionnaire (BIDQ).11 There are also condi-
tion-specific BI tools such as the Body Image 
Scale (BIS) for IBD.12
Both condition-specific symptoms and 
treatments may contribute to BID in patients 
with IBD, particularly during periods of 
active disease rather than remission. Symp-
toms can include urgent bowel movements, 
bloating, excess wind, fatigue, skin problems 
and ulcers. Treatment with steroids can be 
associated with weight gain, acne and mood 
swings.13 Surgeries may also impact on BI due 
to scarring and implementation of a stoma.14 15 
Those suffering with IBD or BID are at an 
increased risk of mental health issues16 17; this 
could be worse for patients living with both 
conditions. Furthermore, most patients with 
IBD are diagnosed at adolescence,18 when 
BI is important. BI is currently not routinely 
considered in the management of IBD.
No existing or ongoing systematic reviews 
on BI in IBD have been identified. However, 
multiple primary studies, mainly cross-sec-
tional in nature, assess BI as an outcome in 
patients with IBD, with disparate results. A 
systematic review is therefore warranted to 
synthesise and clarify the evidence base.
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The following four questions will be addressed:
1. What tools are used to measure BI in patients with IBD 
and what are their components?
2. What is the prevalence and severity of BID in patients 
with IBD?
3. What factors are associated with BID in patients with 
IBD?
4. Is there an association BID in patients with IBD and 
QoL?
Methods
This systematic review has been reported according to 
the Preferred Reporting Items of Systematic Reviews 
and Meta-Analysis guidelines.19 A protocol was previ-
ously registered (PROSPERO (CRD42018060999)) and 
submitted for publication and is currently in process.20 
A summary of the methods is reported below. Selection, 
data extraction and quality assessment were carried 
out by two independent reviewers with disagreements 
resolved through discussion or third reviewer.
search strategy
Bibliographic databases (EMBASE, MEDLINE, 
PsycINFO, Cochrane CENTRAL) were searched to April 
2018 using combinations of index and text terms for IBD 
and BI (see online supplementary table 1 for MEDLINE 
strategy). Strategies were adapted for each database and 
run without date or language restrictions. Trial regis-
tries ( ClinicalTrials. gov, EU Clinical Trial Register) were 
searched for ongoing trials and reference lists of included 
studies were checked.
screening and selection criteria
Study eligibility was based on the following criteria:
Study design
Any primary study reporting quantitative data.
Population
Patients of any age diagnosed with IBD. At least 50% of 
population must have IBD unless results are reported 
separately for subgroups of individuals with IBD.
Tools
Any tool measuring any aspect of BI (including QoL tools 
that had at least one BI-related domain or question).
Studies were also eligible (for questions 2–4) where 
they reported any measure of prevalence/frequency and 
severity of BID in patients with IBD; data on associations 
between any factor in patients with IBD and BID; or any 
association between BI and QoL measures in patients 
with IBD, including associations between two separate 
domain measures of the same tool.
Exclusion criteria
Case reports, qualitative research and conference 
abstracts published 3 years before the date of the searches.
Reasons for exclusion were recorded.
data extraction
A piloted data extraction form was used. Examples of the 
type of data extracted are shown below.
Study characteristics
Study design, aim and setting, inclusion/exclusion 
criteria, recruitment methods, follow-up period.
Participant characteristics
Number of patients, age, gender, type of IBD, disease 
severity and activity, body mass index (BMI), comorbid-
ities, therapy/surgery.
Data for synthesis/analysis
BI measurement tool, components of tools/scales, data 
on BID (eg, BI scores, prevalence, thresholds for deter-
mining BID), factors associated with BI dissatisfaction 
and strength of association, QoL measures, strength of 
association between BID and QoL.
Quality assessment
Quality assessment was based on critical appraisal check-
lists for both prevalence and cross-sectional analytical 
studies from the Joanna Briggs Institute.21 Studies solely 
included for question 1 were not quality assessed as the 
objective of this question was to compile a list of BI tools.
Important quality items included sample selection, 
response rate during enrolment in the study, clear inclu-
sion criteria and measurement of outcomes in a valid and 
reliable way.
Analysis
A narrative synthesis was carried out separately for each 
question, with key findings tabulated. Substantial heter-
ogeneity relating to populations, tools and settings was 
apparent in the included studies meaning that meta-anal-
ysis was not appropriate. Consistencies and discrepancies 
in findings between studies were noted and discussed in 
the context of any likely sources of heterogeneity. Quality 
assessment findings were used when considering the 
strength of evidence for the latter three questions.
results
Database searches identified 587 records and 5712 14 22–76 
studies were included, with some studies eligible for 
multiple questions (see figure 1 for selection process 
and reasons for exclusion). All 57 papers reported 
using BI tools, 3114 22–26 30 31 33–39 42 47 50 51 53 54 58 60–65 67 69 
71 72 reported prevalence or mean/median BI scores, 
1614 23 24 30 34–36 47 54 58 60 61 63 65 67 71 studies presented 
factors associated with BID and 814 22–24 34 61 65 71 studies 
reported correlations between QoL and BI.
Question 1: what tools are used to measure BI and what are 
their components?
Of the 57 studies measuring BI, 51 were cross-sec-
tional while the others varied (case–control,25 prospec-
tive cohort,51 65 case series,39 randomised controlled 
trial64 and non-randomised intervention study42). Study 
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Figure 1 Selection process of records for inclusion/exclusion detailed in a Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses flowchart. BID, body image dissatisfaction; IBD, inflammatory bowel disease.
populations included adults and children in settings 
including outpatients, presurgery/postsurgery, summer 
camps and online registries, from countries across the 
world. Twenty studies focused on BI as one of the main 
outcomes, but only six of these studies were non-surgery 
based.
Fifteen tools were identified (table 1). Seven tools 
were specifically for BI and eight were QoL tools which 
included a BI domain or question(s). The most frequently 
applied tool specific to BI was the Body Image Question-
naire (BIQ) which was used in 14 studies. The BIS was 
used in five studies and is the only tool validated in an 
IBD population. IMPACT-III (or earlier IMPACT-II) is a 
validated QoL questionnaire aimed at adolescents and 
children with IBD and includes a BI domain. It was used 
across 18 studies. The remaining 12 tools were used in 
only one to three studies, respectively.
None of the tools included had a clear cut-off point 
for defining BID but offered an indication of increasing 
or decreasing likelihood of dissatisfaction. In some 
tools, a higher score indicated better BI (BIQ, EORTC, 
DUX-25). In others, a higher score indicated increased 
BID (IMPACT, BIS, RFIPC, IBDSI (Inflammatory bowel 
disease stress index), Body Image Self-Consciousness 
during Intimacy Scale, BIDQ and ASWAP).
Tools where items had similar themes were grouped 
to show general focus of BI questions and are shown in 
table 2.
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Table 1 Tools identified and used across included studies
Measurement tool Type of tool
Intended target 
population
Is tool 
validated? Scoring
Number 
of studies 
tool used 
in
Body image tools
ASWAP Body image Initially used in 
patients with 
scleroderma
Yes but not 
in patients 
with IBD
15 items rated on 7-point scale. 
Questions corresponding to items 
4–11 were reverse scored such 
that higher scores reflect greater 
dissatisfaction
1
Askevold’s Body 
Image Test
Body image Unclear Unclear Unclear 2
Body Image and 
Self-Consciousness 
During Intimacy
Scale
Body image and sexual 
self-consciousness
Women No 0–75, higher scores poorer body 
image
1
BIA/BIA-P Body image Adults, no specific 
clinical population
Unclear Based on body image silhouettes 
ranging in size. Score=difference 
between current body size and 
ideal body size
1
BIQ Body image Originally caesarean 
or appendectomy 
patients, now 
patients with IBD
No 5–20, higher score better body 
image
14
BIS Body image Patients with cancer Yes 0–30, lower score better body 
image
5
Cash Body Image 
Disturbance 
Questionnaire
Body image Range of clinical 
groups
Yes but not 
in patients 
with IBD
7–35, higher score poorer body 
image
2
QoL tools with a body image component
DUX-25 Quality of daily functioning 
(1 of 4 domains relate to 
body image)
School-age children No Higher scores, better QoL 1
EORTC-QLQ-CR38 QoL questionnaire (3 of 38 
items relate to body image)
Patients with cancer Yes but not 
in patients 
with IBD
38 items with four category 
responses. Functional scales: 
higher score higher functioning. 
Symptoms scales: higher score 
higher level of symptoms
1
EORTC-QLQ-CR29 QoL questionnaire (3 of 29 
items relate to body image)
Patients with cancer Yes but not 
in patients 
with IBD
29 items with four category 
responses
Functional scales: higher score 
higher functioning Symptoms 
scales: higher score higher level of 
symptoms
1
IMPACT-III or 
IMPACT II
Health-related QoL (3 of 35 
items relate to body image)
Children and 
adolescents with 
IBD
Yes 35–175, higher scores better QoL 18
Inflammatory Bowel 
Disease Stress 
Index
Assessing the extent to 
which IBD has caused 
alterations in lifestyle (1 
of 10 items relate to body 
image)
Patients with IBD Unclear Eight scales with a score of 0–3 (no 
impact–a great deal of impact)
1
RFIPC QoL questionnaire (1 item 
of 25 relate to body image)
Patients with IBD Yes 0–100, higher score poorer QoL 3
Stoma Quality of 
Life Scale
Stoma-related (5 items of 
19 relate to body image 
and sexuality)
Patients with stoma Yes (in 
ostomy 
patients)
Five scales, 19 questions. Each 
scored 1–5 (never–always). 
Average scores for each scale 
calculated
3
Continued
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Measurement tool Type of tool
Intended target 
population
Is tool 
validated? Scoring
Number 
of studies 
tool used 
in
The Karolinska 
Psychodynamic 
Profile
Assessment of stable 
modes of mental 
functioning and character 
traits (1 subscale and 3 
of 18 items relate to body 
image)
No specific clinical 
population
Yes Each subscale is graded from 1 to 
3 (most normal–least normal)
2
ASWAP, Adapted Satisfaction with Appearance scale; BI/BIA-P, Body Image Assessment/Body Image Assessment Preadolescent; 
BIQ, Body Image Questionnaire; BIS, Body Image Scale; DUX-25, Dutch Children’s AZL/TNO Quality of Life Questionnaire; EORT-
QLQ-CR38/EORT-QLQ-CR29, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life questionnaire 
for Colorectal Cancer; IBD, inflammatory bowel disease; IMPACT-II/IMPACT-III, a measure of health-related quality of life in paediatric 
inflammatory bowel disease; QoL, quality of life; RFIPC, Rating Form of IBD Patient Concerns.
Table 1 Continued
Table 2 Body image tools with similar questions grouped into overarching themes
Body 
image 
tool 
Components
Satisfaction 
with 
appearance Attractiveness
Socialising
/work
Avoidance 
of people 
or tasks
Feeling 
feminine/ 
masculine
Effect of 
disease 
on body
Scar 
satisfaction
Satisfaction 
with body 
both naked 
and dressed
Distressing 
thoughts
BIS ✓ ✓ ✓ ✓ ✓ ✓
BIQ ✓ ✓ ✓ ✓ ✓ ✓
CBIDQ ✓ ✓ ✓ ✓ ✓
ASWAP ✓ ✓ ✓ ✓ ✓
Similar components of tools were grouped into themes shown above. Askevold’s Body Image Test (no information in paper or online), 
Body Image and Self-consciousness during Intimacy Scale (too specific) and the Body Image Assessment (based on figural drawing 
scales) were not included.
ASWAP, Adapted Satisfaction with Appearance Scale; BIQ, Body Image Questionnaire; BIS, Body Image Scale; CBIDQ, Cash Body 
Image Disturbance Questionnaire.
What is the prevalence of BI dissatisfaction in patients with 
IBd?
Thirty-one studies including a total of 3634 
patients reported on prevalence or severity of BID 
(see table 3 for study characteristics). Seventeen 
studies14 22 23 25 30 31 38 42 53 54 58 60 61 65 69 71 72 included 
both patients with ulcerative colitis (UC) and Crohn’s 
disease (CD). Ages ranged from 2 to 71, and 18 
studies22 30 38 40–42 51–53 57 59–62 69 70 72 75 included only chil-
dren/adolescents. Fourteen studies24–26 33–37 39 47 50 63 64 67 
included surgery patients and one study included only 
women.71
Only three studies reported prevalence. Brown et al26 
found that 21%–34% of patients with UC reported nega-
tive impacts on BI using BIQ. McDermott et al14 found 
that 87% of patients reported some form of concern 
about an aspect of their BI using the Cash Body Image 
Disturbance Questionnaire. Muller et al58 reported that 
66.8% of patients with IBD stated they had impaired BI 
based on a researcher-devised questionnaire. The other 
28 studies reported mean/median BI scores based on a 
range of tools.
In studies with populations undergoing surgery, it 
was found that there was no significant difference in 
BI scores (using the BIQ) after laparoscopic or open/
conventional surgery in patients with IBD.33–35 63 77 Only 
one study found BI scores to be significantly improved 
after laparoscopic surgery compared with conventional 
surgery in CD.36.
BI was included as an outcome across 31 studies. All 
but one study compared results within the included IBD 
population, for example, UC versus CD, surgery versus 
no surgery and men versus women. Bel et al23 found that 
women with IBD with disease in remission scored compa-
rably with women in a healthy population. One longitu-
dinal study by Saha et al65 measured scores over 2 years 
and found that BI did not change despite improvements 
in symptoms.
What factors are associated with BId in patients with IBd?
Sixteen studies14 23 24 30 34–36 47 54 58 60 61 63 65 67 71 totalling 
2333 patients with IBD reported the association between 
various factors and BID (see table 4). Factors included 
those related to demographics as well as disease and treat-
ment-related characteristics. Ten studies14 24 34–36 47 63 65 67 71 
used a specific BI tool and six34–36 47 63 67 focused on compar-
ative surgery techniques. Three studies30 60 61 included a 
paediatric population; the remaining studies included 
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adults. BI was one of the main outcomes in most of these 
studies and the study by Saha et al65 was the first longitu-
dinal follow-up of BID in IBD according to the authors.
In 6/10 studies,14 23 54 58 63 65 female gender was found 
to be significantly associated with increased BID. One 
study58 reported the odds of BID was over three times 
more in women than men (p=0.001), with strong associa-
tions reported in the other five studies. Increased disease 
activity was found to have a significant but moderate posi-
tive association in 7/9 studies.14 23 34 61 65 67 71
Other factors found to be significantly associated with 
increased BID included steroid use,14 60 65 71 age,14 23 
increased BMI,14 71 smoking14 and fatigue23 (table 4). Saha 
et al65 also found a significant association between extrain-
testinal manifestations and increased BID, but were 
the only study to assess this. Laparoscopic surgery was 
found to be associated with improved body image in 2/6 
studies.36 67 Ileal pouch-anal anastomosis (IPAA) seemed 
to result in patients being satisfied with their body image 
in two studies,24 26 but they lacked a comparative surgery 
group. One study50 compared IPAA and ileostomy and 
found better body image scores in the IPAA group. No 
significant associations were found between disease 
subtype and increased BID.
Is there an association between BId and quality of life in 
patients with IBd?
Eight studies14 22–24 34 62 65 71 explored a potential asso-
ciation between BID and QoL across a total of 1371 
patients, with seven presenting a significant association. 
Three studies22 24 61 (table 4) focused on younger popula-
tions with the rest including adults only. The majority of 
studies included populations with both UC and CD while 
two 24 34 included only one subtype.
Statistically significant weak to moderately strong 
correlations were present in five studies22 23 34 61 71 ranging 
from r=0.34 to r=0.67. Furthermore, McDermott et al14 
found that when using the BI scale, there was a signif-
icant difference in scores between those with good or 
poor QoL. Trindade et al71 found that BI was positively 
correlated with psychological and physical QoL. Saha et 
al65 found that a one-unit increase in the total ASWAP 
score (indicating poorer body image) was associated with 
a 0.62 decrease in QoL score (p<0.0001).
Various QoL tools (see table 1) were used across studies 
with some using more than one. Four of these question-
naires used (IMPACT II and III, GIQLI (Gastrointestinal 
Quality of Life Index) and WHOQOL-BREF (World 
Health Organization Quality of Life Instruments)) 
contain a question or domain on BI, potentially making 
them more likely to correlate with BI questionnaires.
risk of bias
The 31 studies relevant for questions 2–4 were assessed 
using criteria from the Joanna Briggs Institute critical 
appraisal tools for analytical cross-sectional and prev-
alence designs (online supplementary table 2). Only 
cross-sectional data were relevant for the review. Poor 
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reporting of quality criteria in many studies made quality 
assessment difficult. Where criteria were reported, the 
overall quality was variable. Most studies had some areas 
of low and higher quality. Only one study, McDermott et 
al,14 was able to demonstrate adequate response rates, 
validated outcome measurement tools and adjustment 
for confounders. However, Chouliaras et al,30 Trindade et 
al,71 Lee et al51 and Bel et al23 adjusted for confounders 
and used validated outcome measurement tools but 
lacked adequate response rates.
Twenty studies (64.5%) used an appropriate sample 
frame with acquisition of patients from outpatient 
settings, IBD registries or healthcare records. Eighteen 
studies (58.1%) clearly reported inclusion criteria applied 
when recruiting participants. Only 12 studies (38.7%) 
had response rates >75%. Fifteen studies (48.4%) used 
a tool which had been validated using factor analysis and 
internal consistency analysis to measure BI. The others 
used non-validated tools. Twelve studies14 35 50 51 58 64 65 72 
adjusted for potential confounders such as age, gender, 
BMI and previous surgery often using multiple regression 
models. Several studies reported limited demographic 
data. It should also be noted that sample sizes of many of 
the studies were small and CIs were mostly not presented.
dIscussIon
summary of findings
Overall, 15 different tools were used across 57 studies to 
measure BI in patients with IBD. These included QoL 
tools incorporating BI questions or domains, BI tools 
and other adapted questionnaires. None offer a defining 
threshold for presence or absence of BID, which is not 
commonly considered as a specific psychological disorder 
unlike body dysmorphia.
It remains unclear whether patients with IBD suffer 
with BID more so than the general population as most 
studies reported mean values with no reference to healthy 
population values. Three studies estimated a prevalence 
of a negative BI based on one question, and this varied 
between 21% and 81%. This wide variation likely reflects 
the differences in tools and study characteristics. All three 
studies were based on self-report questionnaires with a 
wide age range and registry or hospital-based population.
Certain factors including female gender, disease activity 
and steroid use were consistently found to be significantly 
associated with increased BID in patients with IBD. There 
was also a significant association between increasing BID 
and decreasing QoL reported in eight studies. These 
findings are consistent with a previous narrative review78 
assessing BID and sexual functioning in patients with 
IBD.
strengths and weaknesses of the review
This is the first systematic review assessing BID in an IBD 
population, and a robust methodology was employed 
to ensure that bias and errors were minimised. A sensi-
tive search strategy means that it is unlikely that relevant 
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studies were missed and over 50 studies have contributed 
to the evidence base in an area previously unexplored by 
a systematic review.
The review has some limitations. Some of the extracted 
data are based on abstracts only where full texts could not 
be obtained from the authors. This will have resulted in 
some missing information.
Furthermore, qualitative studies were not included as 
this was considered beyond the scope of this review. It is 
likely that there are qualitative studies which could offer 
a deeper insight into perception of BI in patients with 
IBD.
strengths and weaknesses of the evidence
There are some weaknesses within the included evidence. 
All studies had some areas of high risk of bias or had 
poorly reported methodological criteria, thus hampering 
quality assessment. Some studies had very low response 
rates leading to possible under-representation of certain 
groups. Few studies adjusted for confounders which 
could have resulted in overestimates of associations.
A further issue is the lack of healthy control groups. 
Although it appears that patients with IBD are concerned 
about BI, it is difficult to determine whether they are 
affected more than the general population. However, 
it has been found that children and adolescents with 
chronic illnesses such as asthma, cystic fibrosis and 
diabetes do have increased BID compared with healthy 
peers.79
Non-validated tools were often used for measuring BI 
and the reliability and validity of findings based on these 
is therefore unknown. There is also still little known 
about potential changes in BI perception over time.
Findings in context
This review is consistent with findings from the narrative 
review by Jedel et al78 which found that BI could poten-
tially be a problem in patients with IBD. While surgery 
has been found to be an important contributing factor 
in BID in other research,80 it is unclear how it impacts 
on patients with IBD. An association between BID and 
poorer QoL has been highlighted in both.
Females and adolescents are more likely to be 
concerned with BI and to suffer with BID compared 
with men and older people.81–86 While we found incon-
sistent results surrounding age, IBD is often diagnosed 
in adolescence when BID could be more of a concern.
In oncology, BI is more widely researched. One study 
suggested patients with gynaecological cancer suffered 
with BID which predicted emotional well-being.87 
Another study with patients with advanced cancer 
suggested BID was associated with depression, anxiety 
and fatigue.88 Qualitative research in pregnancy89 and 
systematic lupus90 suggests BI can affect medication 
compliance and that patients would like more support 
around dealing with BI issues. This could also be true 
for patients with IBD.
Finally, a previous systematic review found that 
children with chronic conditions were more likely to 
be dissatisfied with their body than healthy peers.79 
Although patients with IBD were not included, patients 
with similar chronic diseases like diabetes, cancer, 
asthma and scoliosis were suggesting patients with IBD 
could be similarly affected.
Implications
This evidence identified in this review suggests an asso-
ciation between BID and poorer QoL as well as finding 
factors influencing BI in patients with IBD. There were, 
however, limitations to the evidence in terms of meth-
odological quality and/or reporting. Also, results were 
difficult to compare across studies. More promisingly, 
BI is becoming an increasingly assessed outcome, high-
lighting the need for continued research in this area.
Current research suggests that age, gender, medica-
tion and disease activity in IBD may impact on BI. These 
could be taken into account by clinicians and patients 
by altering therapy or targeting comorbidities which 
could have a beneficial effect on BID. Interventions to 
improve BI could be incorporated into treatment strat-
egies, which may in turn help to improve QoL. A recent 
systematic review91 found that stress management, 
mindfulness and talking therapies may offer small to 
moderate improvements in BI; however, there is a lack 
of evidence from good randomised controlled trials.
Future research
Future research should focus on developing a consensus 
around which validated tool or tools are best suited to 
measuring BID in an IBD population. While we describe 
validity of tools such as the Body Image Scale, we have 
not independently verified this; therefore, we could 
not recommend a particular tool. Defining thresholds 
may allow estimation of the prevalence of BID in this 
population. Establishing reference values in a healthy 
population would allow for more meaningful interpre-
tation of BID scores across different chronic diseases. 
Enrolling patients from diagnosis and following them 
over time would be useful to measure how BI changes 
with duration, activity of disease and treatment. While 
more severe IBD symptoms or invasive treatment 
options may exacerbate BID, BID itself and any associ-
ated anxiety or depressive symptoms may in turn exac-
erbate IBD symptoms,92 93 and future research should 
also address this association. If BID is recognised and 
treated early, it may contribute to preventing worsening 
disease course. It may also be useful to encourage the 
use of BI as a patient-reported outcome in future IBD 
studies. This would increase data on BID and lead to a 
greater understanding of the condition.
conclusIon
In conclusion, the evidence suggests a detrimental 
effect of IBD on BI, but uncertainty remains due a 
lack of comparison data from healthy populations. 
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Associations of BID with disease-related factors such as 
steroid treatment, fatigue, disease activity and surgery 
are apparent and findings suggest a correlation between 
impaired BI and poorer QoL. These results should be 
cautiously interpreted due to risk of bias and/or poor 
reporting of methodological criteria among included 
studies, and the wide variation between populations, BI 
tools and scoring systems. Future studies should make 
use of validated measurement tools and include BI as a 
main outcome where appropriate.
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